Carbon Modular Radial Head replacement ( DrugBank: Carbon )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02405234 (ClinicalTrials.gov) | January 2009 | 4/11/2014 | Ascension PyroCarbon Radial Head Study | Safety and Effectiveness Study of Ascension PyroCarbon Radial Head Compared to Ascension Metal Radial Head | Degenerative Arthritis;Radial Head Fracture;Rheumatoid Arthritis | Device: Carbon Modular Radial Head replacement;Device: Metal Radial Head replacement | Integra LifeSciences Corporation | NULL | Terminated | 18 Years | 85 Years | All | 78 | N/A | United States |